Phase 2 Study of Chidamide for MRD-Positive DLBCL in First Complete Remission
A phase 2 study is underway to assess chidamide maintenance therapy in adults with MRD-positive DLBCL post-complete response.
Therapeutic Area
Therapeutic area intelligence for DLBCL with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.